Literature DB >> 25560736

Catheter-based interventions for modified Blalock-Taussig shunt obstruction: a 20-year experience.

Mathilde Bonnet1, Jérôme Petit, Virginie Lambert, Philippe Brenot, Jean-Yves Riou, Claude-Yves Angel, Emre Belli, Alban-Elouen Baruteau.   

Abstract

Thrombotic occlusion of a modified Blalock-Taussig (BT) shunt is rare, leading to life-threatening hypoxemia. Rescue percutaneous interventions may allow recanalization of the systemic-to-pulmonary shunt but data on large patients' scales are lacking. We aimed to describe safety and effectiveness of catheter-based interventions to restore modified BT shunt patency. All patients who attempted transcatheter intervention for thrombotic occlusion of a modified BT shunt at our Institution from 1994 to 2014 were reviewed. Characteristics, management, and outcomes of the 28 identified patients were analyzed. Thirty-three procedures were performed at a median age of 0.6 years old (range 0.03-32.1 years) and a median weight of 5.8 kg (range 2.2-82 kg). Percutaneous intervention consisted in 33 balloon angioplasty (100 %) and 14 stent implantations (42.4 %). Thrombolytic agents were also used in 6.1 % cases. No peri-procedural death occurred but complications were observed in five patients (15.2 %), including one catheter-induced transient complete atrioventricular block, one cardiac tamponade, and one massive thrombo-embolic stroke. Early procedural success was obtained in 28 patients (84.8 %) and remained long-lasting in 26 patients (78.8 %). A young age and a low body-weight at the time of the procedure were significantly associated with procedural failure (p = 0.0364 and p = 0.0247, respectively). Although technically challenging and carrying potential major complications, transcatheter intervention can be considered as an efficient rescue strategy to restore patency in case of thrombotic obstruction of a modified BT shunt.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25560736     DOI: 10.1007/s00246-014-1086-0

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  30 in total

1.  Stent implantation to maintain patency of a stenosed Blalock Taussig shunt.

Authors:  Amjad Kouatli; Jameel Al-Ata; M Omar Galal; Muhammed A Amin; Arif Hussain
Journal:  Asian Cardiovasc Thorac Ann       Date:  2005-09

2.  The tetralogy of Fallot; diagnosis and indications for operation; the surgical treatment of the tetralogy of Fallot.

Authors:  H B TAUSSIG; A BLALOCK
Journal:  Surgery       Date:  1947-01       Impact factor: 3.982

3.  Transcatheter recanalization and subsequent stent implantation for the treatment of early postoperative thrombosis of modified Blalock-Taussig shunts in two children.

Authors:  M Peuster; C Fink; H Bertram; T Paul; G Hausdorf
Journal:  Cathet Cardiovasc Diagn       Date:  1998-12

4.  Stenting of modified and classical Blalock-Taussig shunts--lessons learned from seven consecutive cases.

Authors:  Thomas Krasemann; Aphrodite Tzifa; Eric Rosenthal; Shakeel A Qureshi
Journal:  Cardiol Young       Date:  2011-03-17       Impact factor: 1.093

5.  Modified Blalock Taussig shunt: a not-so-simple palliative procedure.

Authors:  Verena Dirks; René Prêtre; Walter Knirsch; Emanuela R Valsangiacomo Buechel; Burkhardt Seifert; Martin Schweiger; Michael Hübler; Hitendu Dave
Journal:  Eur J Cardiothorac Surg       Date:  2013-03-28       Impact factor: 4.191

6.  Balloon dilation angioplasty of Blalock-Taussig shunts.

Authors:  G R Marx; H D Allen; T W Ovitt; W Hanson
Journal:  Am J Cardiol       Date:  1988-10-01       Impact factor: 2.778

7.  Balloon dilatation of critically obstructed modified (polytetrafluoroethylene) Blalock-Taussig shunts.

Authors:  M Marasini; P Dalmonte; G Pongiglione; G Dolcini; M Bosoni; D Ribaldone; S Caponnetto
Journal:  Am J Cardiol       Date:  1994-02-15       Impact factor: 2.778

8.  Percutaneous transluminal balloon angioplasty of stenotic standard Blalock-Taussig shunts: effect on choice of initial palliation in cyanotic congenital heart disease.

Authors:  L A Marks; A V Mehta; D Marangi
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

9.  [Fibrinolytic treatment. First results during the early postoperative period].

Authors:  V Batchvarova; E Daskalov; A Morosova
Journal:  Arch Mal Coeur Vaiss       Date:  1979-12

10.  Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis.

Authors:  Saurav Chatterjee; Anasua Chakraborty; Ido Weinberg; Mitul Kadakia; Robert L Wilensky; Partha Sardar; Dharam J Kumbhani; Debabrata Mukherjee; Michael R Jaff; Jay Giri
Journal:  JAMA       Date:  2014-06-18       Impact factor: 56.272

View more
  3 in total

1.  Catheter Intervention for Flow Regulatory Clips on Palliative Shunts and Conduits in Patients with Congenital Heart Disease.

Authors:  Yuji Doi; Sung-Hae Kim; Mizuhiko Ishigaki; Keisuke Sato; Jun Yoshimoto; Norie Mitsushita; Masaki Nii; Akio Ikai; Kisaburo Sakamoto; Yasuhiko Tanaka
Journal:  Pediatr Cardiol       Date:  2022-07-20       Impact factor: 1.838

2.  Computational Fluid Dynamics Characterization of Two Patient-Specific Systemic-to-Pulmonary Shunts before and after Operation.

Authors:  Neichuan Zhang; Haiyun Yuan; Xiangyu Chen; Jiawei Liu; Qifei Jian; Meiping Huang; Kai Zhang
Journal:  Comput Math Methods Med       Date:  2019-02-03       Impact factor: 2.238

3.  Stenting of modified Blalock-Taussig shunt in adult with palliated pulmonary atresia and ventricular septal defect: a case report.

Authors:  Julia Illner; Holger Reinecke; Helmut Baumgartner; Gerrit Kaleschke
Journal:  Eur Heart J Case Rep       Date:  2019-11-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.